本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Akero Therapeutics

45.44
-1.2900-2.76%
盘后46.000.5600+1.23%16:37 EDT
成交量:79.78万
成交额:3,657.95万
市值:36.35亿
市盈率:-12.02
高:47.67
开:46.81
低:45.40
收:46.73
52周最高:58.40
52周最低:21.34
股本:7,998.90万
流通股本:6,777.24万
量比:1.40
换手率:1.18%
股息:- -
股息率:- -
每股收益(TTM):-3.7801
每股收益(LYR):-3.7544
净资产收益率:-31.14%
总资产收益率:-20.36%
市净率:3.54
市盈率(LYR):-12.10

数据加载中...

2024/09/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/09

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/09

重要事件披露

Form 8-K - Current report
2024/07/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/12

重要事件披露

Form 8-K - Current report
2024/05/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/10

重要事件披露

Form 8-K - Current report
2024/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/18

重要事件披露

Form 8-K - Current report
2024/03/15

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/06

重要事件披露

Form 8-K - Current report
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/04

重要事件披露

Form 8-K - Current report
2024/02/29

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans